SOLICITATION NOTICE
66 -- X-ray Fluorescence Spectroscopy Analyzer
- Notice Date
- 8/4/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-09-1061201
- Point of Contact
- Karen R. Petty, Phone: 301-827-8774
- E-Mail Address
-
karen.petty@fda.hhs.gov
(karen.petty@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Synopsis: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6. This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code 334516, is to notify contractors that the Food and Drug Administration (FDA) is seeking competition of this requirement in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procedures. Under the simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This synopsis is designated for 100% Small Business Set Aside competition for a firm fixed-price purchase order. Prospective offerors are responsible for monitoring the FedBizOpps website for the release of any amendments to this solicitation. Hard copies will be provided to individuals eligible under the Americans with Disabilities Act and Rehabilitation Act upon request. This combined synopsis solicitation is issued as a Request for Quotation (RFQ). The FDA intends to award a purchase order for an X-Ray Fluorescence (XRF) Spectroscopy Analyzer. Specifications for the X-Ray Fluorescence (XRF) Spectroscopy Analyzer include: 1. Handheld format, weighing less than 10 pounds, and battery operated. 2. Capable of measuring x-ray fluorescence from nearly all elements heavier than Magnesium. 3. Capable of collecting and analyzing more than 90,000 x-ray counts per second. 4. Resolution of less than 1.5eV at 5.9 keV and and 100,000 counts per second. 5. User accessible calibration including selection of calibration order. Capable of user-specified linear, quadratic, cubic and higher order polynomial calibrations. 6. Instrument shall be capable of operation in gauge mode, empirical calibration mode, fundamental parameters mode and analytical mode. 7. Instrument shall have at least 5 automatically interchangeable filters. 8. Instrument shall allow user to develop methods that utilize at least three filters in a programmable sequence, with user specified calibration. 9. Calibrations shall be prepared by user from user provided reference materials. 10. Silicon drift detector is required for increased sensitivity and resolution. 11. Vacuum system shall accompany the instrument to facilitate the sensitive determination of light elements. 12. Instrument shall include a stand to support the instrument on a benchtop. 13. Instrument shall include an interface to a user supplied computer via USB or similar common interface. 14. Instrument shall include desktop computer software for analysis and display of data from the handheld instrument. 15. Desktop software shall allow direct control of the handheld XRF spectrometer, for calibration and method development. EVALUATION AND AWARD: Award will be made to the party whose quote offers the best value to the Government, technical, price, and other factors considered. The Government may award this purchase order to other than the lowest price technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor "Meeting or Exceeding the Requirement," (2) Past performance and 3) Price-- Technical Capability is significantly more important than price. DELIVERY LOCATION: U.S. Food and Drug Administration Philadelphia, PA 19106 It is the responsibility of the contractor to be familiar with the applicable clauses and provisions. The clauses may be accessed in full text at these addresses: www.acqnet.gov. The provision 52.212-1, Instructions to Offerors-Commercial applies to this acquisition. Offerors should complete their representations and certifications at Online Representations and Certifications Application (ORCA) at http://orca.bpn.gov. The Food and Drug Administration requests responses from qualified sources capable of providing these services in accordance with the attached. FAR provision 52.212-2, Evaluation-Commercial Items applies. FAR Provision, 52.212-3, Offeror Representations and Certifications applies, if the contractor is not registered in ORCA, the vendor shall complete and submit with offer. FAR Clauses 52.212-4 and 52.212-5 apply. The FAR clauses cited in the clause are applicable to this acquisition: 52.219-28, 52.222-3, 52.222-21, 52.222-26, 52.222-36, 52.222-36, 52.222-50, 52.225-13, 52.232-33, and 52.239-1. Government reserves the right to award a purchase order without discussion if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The total number of pages for the technical plan is not expected to exceed twenty (20) pages in length CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. All questions are to be submitted via email to karen.petty@fda.hhs.gov no later than August 7, 2009 4:30 pm, EST. NO PHONE CALLS WILL BE ACCEPTED. This is a REQUEST FOR QUOTATION (RFQ). This announcement constitutes the only solicitation and a written solicitation will not be issued. All quotations are due, via email to: karen.petty@fda.hhs.gov no later than 4:30pm, EST on August 12, 2009. FDA anticipates an award soon after the response date.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-09-1061201/listing.html)
- Place of Performance
- Address: Food and Drug Administration, 200 Chestnut St, Philadelphia, Pennsylvania, 19106, United States
- Zip Code: 19106
- Zip Code: 19106
- Record
- SN01899176-W 20090806/090805000901-48719c280aebb4a0754eb378bdfb8eb4 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |